Effects of supra-physiological changes in human ovarian hormone levels on maximum force production of the first dorsal interosseus muscle

Experimental Physiology

Volumn 90, Issue 2, 2005, Pages 215-223

  Elliott, Kirsty Jayne ^a,e   Cable, Nigel Timothy ^b   Reilly, Thomas ^b   Sefton, Victoria ^c   Kingsland, Charles ^c   Diver, Michael ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^c LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN ACETATE; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN DERIVATIVE; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; TESTOSTERONE;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DORSAL INTEROSSEOUS MUSCLE; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; MUSCLE FORCE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; PREGNANCY; PROGESTERONE BLOOD LEVEL; PUERPERIUM; REPRODUCTION; SECOND TRIMESTER PREGNANCY; SKELETAL MUSCLE; TESTOSTERONE BLOOD LEVEL;

EID: 14944373462     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/expphysiol.2004.028258     Document Type: Article

References (25)

1. Bassey EJ, Mockett S & Fentem PH (1996). Lack of variation in muscle strength with menstrual status in healthy women aged 45-54 years: data from a national survey. European J Appl Physiol 73, 382-386.
2. Beltran Niclos B, Welsh L, Sarwar R & Rutherford OM (1995). Gender and age comparisons of the contractile properties of human quadriceps muscle. J Physiol 483, 131P.
3. Davies DV (1972). Grays Anatomy Descriptive and Applied, pp. 266-268. Longmans, London, UK.
4. De Valk-de Roo GW, Netelenbos JC, Peters-Muller IRA, Voetberg GA, van de Weijer PHM, Bouman AA et al. (1997). Continuously combined hormone replacement therapy and bone turnover: the influence of dydrogesterone dose, smoking and initial degree of bone turnover. Maturitas 28, 153-162.
5. Elliott KJ, Cable NT, Reilly T & Diver MJ (2003). Effect of menstrual cycle phase on the concentration of bioavailable oestradiol and testosterone and muscle strength. Clin Sci 105, 663-669.
6. Fotherby K (1984). Endocrinology of the menstrual cycle and pregnancy. In Biochemistry of Steroid Hormones, ed. Makin HLJ, pp. 409-440. Blackwell Scientific Publications, London.
7. Frontera WR, Hughes VA, Lutz KJ & Evans WJ (1991). A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women. J Appl Physiol 71, 644-650.
8. Click ID & Bennett SE (1981). Psychiatric complications of progesterone and oral contraceptives. J Clin Psychopharmacol 1, 350-367.
9. Greeves JP, Cable NT, Luckas MJM, Reilly T & Biljan MM (1997). Effects of acute changes in oestrogen on muscle function of the first dorsal interosseus muscle in humans. J Physiol 500, 265-270.
10. Greeves JP, Cable NT, Reilly T & Kingsland C (1999). Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clin Sci 97, 79-84.
11. Heikkinen J, Kyllonen E, Kurttila-Matero E, Wilen-Rosenqvist G, Lankinen KS et al. (1997). HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two oestrogen-progestin regimens in healthy postmenopausal women. Maturitas 26, 139-149.
12. Janse de Jonge XAK, Boot CRL, Thom JM, Ruell PA & Thompson MW (2001). The influence of menstrual cycle phase on skeletal muscle contractile characteristics in humans. J Physiol 530, 161-166.
13. Kerlan V, Nahoul K, Le Martelot M & Bercovici J (1994). Longitudinal study of maternal plasma bioavailable testosterone and androstanediol glucuronide levels during pregnancy. Clin Endocrinol 40, 263-267.
14. Onambele NGL, Skelton DA, Bruce SA & Woledge RC (2001). Follow-up study of the benefits of hormone replacement therapy on isometric muscle strength of adductor pollicis in postmenopausal women. Clin Sci 100, 421-422.
15. Phillips SK, Rook KM, Siddle NC, Bruce SA & Woledge RC (1993). Muscle weakness in women occurs at an earlier age than in men, but is preserved by hormone replacement therapy. Clin Sci 84, 95-98.
16. Phillips SK, Sanderson AG, Birch K, Bruce SA & Woledge RC (1996). Changes in maximal voluntary force of human adductor pollicis muscle during the menstrual cycle. J Physiol 496, 551-557.
17. Reilly T (1990). Human circadian rhythms and exercise. Crit Rev Biomed Engineering 18, 165-180.
18. Rutherford OM & Jones DA (1988). Contractile properties and fatigability of the human adductor pollicis and first dorsal interosseus: a comparison of the effects of two chronic stimulation patterns. J Neurol Sci 85, 319-331.
19. Rutherford OM & Jones DA (1992). The relationship of muscle and bone loss and activity levels with age in women. Age Ageing 21, 286-293.
20. Sarwar R, Niclos BB & Rutherford OM (1996). Changes in muscle strength, relaxation rate and fatigability during the human menstrual cycle. J Physiol 493, 267-272.
21. Skelton DA, Phillips SK, Bruce SA, Naylor CH & Woledge RC (1999). Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women. Clin Sci 96, 357-364.
22. Tanaka M, McDonagh MJN & Davies CTM (1984). A comparison of the mechanical properties of the first dorsal interosseus in the dominant and non-dominant hand. European J Appl Physiol 53, 17-20.
23. Tremblay RR & Dube JY (1974). Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 10, 599-605.
24. Wirth JC & Lohman TG (1982). The relationship of static muscle function to use of oral contraceptives. Med Sci Sports Exercise 14, 16-20.
25. Young A, Stokes M & Crowe M (1984). Size and strength of the quadriceps muscles of old and young women. European J Clin Invest 14, 282-287.